Loading...
Clinical utility of ramucirumab in non-small-cell lung cancer
Lung cancer is the leading cause of cancer-related mortality worldwide. Non-small-cell lung cancer (NSCLC) accounts for about 85% of all lung cancer cases and approximately 70% of patients with NSCLC have locally advanced or metastatic disease at presentation. In NSCLC patients with advanced or meta...
Saved in:
| Published in: | Biologics |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6659776/ https://ncbi.nlm.nih.gov/pubmed/31413541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S175034 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|